Background
2018 started off brightly. After 6 cycles of docetaxal PSA went from 47 to 1.8 (May 2018). But once the soft stuff was gone, PCa started progressing again and was back to 4.6 after Cycle 9 (June 2018). MO cancelled Cycle 10 and put me on Enzalutamide. 3 months later PSA had risen to 15.1 (Sep 2018, no impact at all on PSADT) so MO discontinued Enza.
I was then enrolled in PARP inhibitor trial (niraparib). While my germline DNA is clear of any bad mutations, my somatic DNA showed that BRCA2 gene had undergone bi-allele deletion - not mutated but completely missing. MO said that this made me a perfect candidate for PARP inhibitors and I should expect to get better results compared to most people on trial, who typically had a mutation in a single gene.
PARP Inhibitor Results
So I had bone scans, CT scans and PSA test to set my baseline (PSA still rising rapidly and now at 60 by early November). I have just had my 2 month check up (7 Jan 2018) with fresh scans and here are the results:
Bone Scan. At least 5 new osteoblastic foci relative to baseline scan.
CT Scan. Progressive hepatic metastatic disease. Progressive mesenteric and retroperitoneal lymphadenopathy. Progressive intraperitoneal disease. Increase in size of the mass at the prostate bed.
PSA. from 60 to 433 in 2 months.
During this period I have also had 3 hospital admissions.
- left hip effusuion and musculature edema requiring drainage and investigation, found to be caused by metastisis in the medial wall of the left hip joint.
- blocked bowel. Caused by metastastic lymph nodes pushing into the small bowel.
- Internal bleeding in Upper GI tract. Collapsed at home at had 2 litres of blood transfused upon arrival at emergency. This bleed resolved itself, surgeons believe it was due to combination of non-steroids (ibruprofen) used for hip pain, and steroids (dexamethsone 16mg perday) used to treat bowel inflammation following the blockage.
As MO said when reviewing my new scan results "This is bad disease". Niraparib was discontinued. She is most worried about my liver as CT scan showed "numerous hypodense lesions" the largest 29 x 22mm. So I had PSMA GA68 PET scan yesterday.
- if liver lesions are PSMA avid then I will start lutetium 177 ASAP.
- if liver lesions not avid, I will be back to chemo - this time she said it will be cabazitaxal plus carboplatin.
There are still options, no-one has called time yet nor offered a prognosis so let's keep fighting!!